BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29900882)

  • 1. Impact of taxanes on androgen receptor signaling.
    Bai S; Zhang BY; Dong Y
    Asian J Androl; 2019; 21(3):249-252. PubMed ID: 29900882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer.
    Martin SK; Kyprianou N
    Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diving Into Cabazitaxel's Mode of Action: More Than a Taxane for the Treatment of Castration-Resistant Prostate Cancer Patients.
    Mellado B; Jimenez N; Marin-Aguilera M; Reig O
    Clin Genitourin Cancer; 2016 Aug; 14(4):265-70. PubMed ID: 26827258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor splice variants determine taxane sensitivity in prostate cancer.
    Thadani-Mulero M; Portella L; Sun S; Sung M; Matov A; Vessella RL; Corey E; Nanus DM; Plymate SR; Giannakakou P
    Cancer Res; 2014 Apr; 74(8):2270-2282. PubMed ID: 24556717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agents.
    Zhang G; Liu X; Li J; Ledet E; Alvarez X; Qi Y; Fu X; Sartor O; Dong Y; Zhang H
    Oncotarget; 2015 Sep; 6(27):23358-71. PubMed ID: 26160840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation.
    de Morrée E; van Soest R; Aghai A; de Ridder C; de Bruijn P; Ghobadi Moghaddam-Helmantel I; Burger H; Mathijssen R; Wiemer E; de Wit R; van Weerden W
    Prostate; 2016 Jul; 76(10):927-36. PubMed ID: 26997363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin derivatives as therapeutic agents for castration-resistant prostate cancer.
    Ingersoll MA; Miller DR; Martinez O; Wakefield CB; Hsieh KC; Simha MV; Kao CL; Chen HT; Batra SK; Lin MF
    Cancer Lett; 2016 Dec; 383(1):94-105. PubMed ID: 27687622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of taxanes in advanced prostate cancer.
    Cassinello J; Carballido Rodríguez J; Antón Aparicio L
    Clin Transl Oncol; 2016 Oct; 18(10):972-80. PubMed ID: 26856599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor splicing variant 7: Beyond being a constitutively active variant.
    Shao C; Yu B; Liu Y
    Life Sci; 2019 Oct; 234():116768. PubMed ID: 31445027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor signaling-targeted therapy and taxane chemotherapy induce visceral metastasis in castration-resistant prostate cancer.
    Iwamoto H; Izumi K; Shimada T; Kano H; Kadomoto S; Makino T; Naito R; Yaegashi H; Shigehara K; Kadono Y; Mizokami A
    Prostate; 2021 Jan; 81(1):72-80. PubMed ID: 33047850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After Docetaxel.
    Shiota M; Nakamura M; Yokomizo A; Tomoda T; Sakamoto N; Seki N; Hasegawa S; Yunoki T; Harano M; Kuroiwa K; Eto M
    Anticancer Res; 2020 Jan; 40(1):335-339. PubMed ID: 31892584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer.
    Scher HI; Graf RP; Schreiber NA; McLaughlin B; Lu D; Louw J; Danila DC; Dugan L; Johnson A; Heller G; Fleisher M; Dittamore R
    Eur Urol; 2017 Jun; 71(6):874-882. PubMed ID: 27979426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer.
    Taneja SS
    J Urol; 2016 May; 195(5):1472-1473. PubMed ID: 27186729
    [No Abstract]   [Full Text] [Related]  

  • 14. Taxane mechanisms of action: potential implications for treatment sequencing in metastatic castration-resistant prostate cancer.
    Fitzpatrick JM; de Wit R
    Eur Urol; 2014 Jun; 65(6):1198-204. PubMed ID: 23910941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case report.
    Kosaka T; Hongo H; Oya M
    BMC Cancer; 2019 Jun; 19(1):562. PubMed ID: 31185946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing taxane resistance in metastatic castration-resistant prostate cancer: a focus on chaperone proteins.
    Hotte SJ
    Future Oncol; 2017 Feb; 13(4):369-379. PubMed ID: 27712093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted Agents.
    Angelergues A; Efstathiou E; Gyftaki R; Wysocki PJ; Lainez N; Gonzalez I; Castellano DE; Ozguroglu M; Carbonero IG; Flechon A; Borrega P; Guillot A; Balea BC; Le Moulec S; Esteban E; Munarriz J; Rubio G; Birtle AJ; Delanoy N; Bellmunt J; Oudard S
    Clin Genitourin Cancer; 2018 Aug; 16(4):e777-e784. PubMed ID: 29550200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cabazitaxel--a next-generation taxane for the treatment of patients with metastatic castration-resistant prostate cancer].
    Ecstein-Fraisse E; Su Z
    Gan To Kagaku Ryoho; 2014 Jul; 41(7):817-22. PubMed ID: 25131866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular complexity of taxane-induced cytotoxicity in prostate cancer cells.
    Mang J; Merkle K; Heller M; Schüler J; Tolstov Y; Li J; Hohenfellner M; Duensing S
    Urol Oncol; 2017 Jan; 35(1):32.e9-32.e16. PubMed ID: 27692847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multinucleation and Mesenchymal-to-Epithelial Transition Alleviate Resistance to Combined Cabazitaxel and Antiandrogen Therapy in Advanced Prostate Cancer.
    Martin SK; Pu H; Penticuff JC; Cao Z; Horbinski C; Kyprianou N
    Cancer Res; 2016 Feb; 76(4):912-26. PubMed ID: 26645563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.